Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cardiometabolic Comorbidities in Psoriasis and Psoriatic Arthritis
L. Puig
International Journal of Molecular Sciences (2017) Vol. 19, Iss. 1, pp. 58-58
Open Access | Times Cited: 108

Showing 1-25 of 108 citing articles:

Impact of Secukinumab on Endothelial Dysfunction and Other Cardiovascular Disease Parameters in Psoriasis Patients over 52 Weeks
Esther von Stebut, Kristian Reich, Diamant Thaçi, et al.
Journal of Investigative Dermatology (2018) Vol. 139, Iss. 5, pp. 1054-1062
Open Access | Times Cited: 191
Systemic Inflammatory Response and Atherosclerosis: The Paradigm of Chronic Inflammatory Rheumatic Diseases
Aikaterini Arida, Athanase D. Protogerou, George D. Kitas, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 7, pp. 1890-1890
Open Access | Times Cited: 163
Psoriasis and Cardiovascular Risk: A Comprehensive Review
Walter Masson, Martín Lobo, Graciela Molinero
Advances in Therapy (2020) Vol. 37, Iss. 5, pp. 2017-2033
Open Access | Times Cited: 150
Sex differences in biomarkers and biologic mechanisms in psoriatic diseases and spondyloarthritis
Stuti Dang, Joan Wither, Igor Jurišica, et al.
Journal of Autoimmunity (2025) Vol. 152, pp. 103394-103394
Open Access | Times Cited: 2
Pathogenesis of Chronic Plaque Psoriasis and Its Intersection With Cardio-Metabolic Comorbidities
Paolo Gisondi, Francesco Bellinato, Giampiero Girolomoni, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 116
Psoriasis and Gut Microbiome—Current State of Art
Karina Polak, Beata Bergler‐Czop, Michał Szczepanek, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4529-4529
Open Access | Times Cited: 86
Interleukin-17 and Interleukin-23: A Narrative Review of Mechanisms of Action in Psoriasis and Associated Comorbidities
Alan Menter, Gerald G. Krueger, So Yeon Paek, et al.
Dermatology and Therapy (2021) Vol. 11, Iss. 2, pp. 385-400
Open Access | Times Cited: 61
Long-term Safety of Secukinumab Over Five Years in Patients with Moderate-to-severe Plaque Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis: Update on Integrated Pooled Clinical Trial and Post-marketing Surveillance Data
Alice B. Gottlieb, Atul Deodhar, Iain B. McInnes, et al.
Acta Dermato Venereologica (2022) Vol. 102, pp. adv00698-adv00698
Open Access | Times Cited: 56
Inflammation and Psoriasis: A Comprehensive Review
Alessandra-Mădălina Man, Meda Sandra Orăsan, Oana-Alina Hoteiuc, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16095-16095
Open Access | Times Cited: 41
Effects of secukinumab on metabolic and liver parameters in plaque psoriasis patients
Sascha Gerdes, Andreas Pinter, C. Papavassilis, et al.
Journal of the European Academy of Dermatology and Venereology (2019) Vol. 34, Iss. 3, pp. 533-541
Open Access | Times Cited: 68
Potential Role of Cytochrome c and Tryptase in Psoriasis and Psoriatic Arthritis Pathogenesis: Focus on Resistance to Apoptosis and Oxidative Stress
Maria Sole Chimenti, Flavia Sunzini, Laura Fiorucci, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 65
Psoriatic arthritis and the association with cardiometabolic disease: a narrative review
Paras Karmacharya, Alexis Ogdie, Lihi Eder
Therapeutic Advances in Musculoskeletal Disease (2021) Vol. 13
Open Access | Times Cited: 54
Transcription Factor Retinoid-Related Orphan Receptor γt: A Promising Target for the Treatment of Psoriasis
Lipeng Tang, Xiaozhi Yang, Yongxin Liang, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 54
The Major Orphan Forms of Ichthyosis Are Characterized by Systemic T-Cell Activation and Th-17/Tc-17/Th-22/Tc-22 Polarization in Blood
Tali Czarnowicki, Helen He, Alexandra Leonard, et al.
Journal of Investigative Dermatology (2018) Vol. 138, Iss. 10, pp. 2157-2167
Open Access | Times Cited: 53
Obesity in psoriatic arthritis
Rubén Queiró, Andrés Lorenzo, Patricia Tejón, et al.
Medicine (2019) Vol. 98, Iss. 28, pp. e16400-e16400
Open Access | Times Cited: 49
Chrysin alleviates imiquimod-induced psoriasis-like skin inflammation and reduces the release of CCL20 and antimicrobial peptides
Hsin‐Ju Li, Nan‐Lin Wu, Chi‐Ming Pu, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 45
The immunoregulatory effects of natural products on psoriasis via its action on Th17 cells versus regulatory T cells balance
Lingyuan Zhong, Nan Luo, Xiaojing Zhong, et al.
International Immunopharmacology (2022) Vol. 110, pp. 109032-109032
Open Access | Times Cited: 25
The cardiometabolic conditions of psoriatic disease
Éric Toussirot, Irène Gallais-Sérézal, F. Aubin
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 24
Transcriptomic Analysis of the Major Orphan Ichthyosis Subtypes Reveals Shared Immune and Barrier Signatures
Madeline Kim, Daniela Mikhaylov, Stephanie M. Rangel, et al.
Journal of Investigative Dermatology (2022) Vol. 142, Iss. 9, pp. 2363-2374.e18
Open Access | Times Cited: 23
Psoriasis, cardiovascular risk factors and metabolic disorders: sex‐specific findings of a population‐based study
Wiebke Sondermann, D.A. Djeudeu Deudjui, Andreas Körber, et al.
Journal of the European Academy of Dermatology and Venereology (2019) Vol. 34, Iss. 4, pp. 779-786
Open Access | Times Cited: 40
Performances of five risk algorithms in predicting cardiovascular events in patients with Psoriatic Arthritis: An Italian bicentric study
Luca Navarini, Domenico Paolo Emanuele Margiotta, Francesco Caso, et al.
PLoS ONE (2018) Vol. 13, Iss. 10, pp. e0205506-e0205506
Open Access | Times Cited: 39
Secukinumab demonstrates high efficacy and a favorable safety profile over 52 weeks in Chinese patients with moderate to severe plaque psoriasis
Lin Cai, Jianzhong Zhang, Xu Yao, et al.
Chinese Medical Journal (2020) Vol. 133, Iss. 22, pp. 2665-2673
Open Access | Times Cited: 35
Clinical, laboratory, and genetic markers for the development or presence of psoriatic arthritis in psoriasis patients: a systematic review
Michelle L M Mulder, Tamara W van Hal, Mark H. Wenink, et al.
Arthritis Research & Therapy (2021) Vol. 23, Iss. 1
Open Access | Times Cited: 29
Effect of Secukinumab on Traditional Cardiovascular Risk Factors and Inflammatory Biomarkers: Post Hoc Analyses of Pooled Data Across Three Indications
Joseph F. Merola, Iain B. McInnes, Atul Deodhar, et al.
Rheumatology and Therapy (2022) Vol. 9, Iss. 3, pp. 935-955
Open Access | Times Cited: 21
Self-assembled hyaluronic acid nanoparticles for the topical treatment of inflammatory skin diseases: Beyond drug carriers
Wang‐Hee Lee, Wook Kim
Journal of Controlled Release (2023) Vol. 366, pp. 114-127
Closed Access | Times Cited: 11
Page 1 - Next Page

Scroll to top